s-disease

Documents about s-disease

• Resting-state alpha reactivity is reduced in Parkinson’s disease and associated with gait variability#197165Repositório Institucional Unesp
• Therapeutic Landscape of Early Symptomatic Alzheimer's Disease Translated into Everyday Practice for Geriatric Providers.#199123NCBI PubMed Central
• Scoping review of preclinical and clinical studies on the role of HMGB1 in heart disease#203121Ora Oxford University Research
• PARP1 deficiency mitigates amyloid pathology, neurodegeneration, and cognitive decline in a familial Alzheimer's disease model.#213896NCBI PubMed Central
• Proteomic analysis in Alzheimer's disease and other dementias: a focus on sex-specific differences.#220848NCBI PubMed Central
• Feature fusion and WOA-GWO optimization for Alzheimer’s disease detection with sparse EEG channels.#221212NCBI PubMed Central
• External sensory cueing on gait in Parkinson's disease: a systematic review and network meta-analysis.#222815NCBI PubMed Central
• Escherichia coli Nissle 1917 alleviates Alzheimer's disease in mice through OmpA-containing outer membrane vesicles.#222836NCBI PubMed Central
• APOE ε4 carriership status enhances age-related changes in Alzheimer’s disease plasma biomarkers concentrations#231420Europe PMC
• Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer’s Disease.#244352NCBI PubMed Central
• Identification of functional non-coding variants affecting Alzheimer's disease risk by Massively Parallel Reporter Assay#252828bioRxiv / medRxiv
• A data-driven Alzheimer's disease progression simulator for retrospective validation and prospective Phase III power design#252875bioRxiv / medRxiv
• Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.#260287NCBI PubMed Central
• Toward Early Diagnosis and Therapeutic Discovery in CLN3 Disease: A Computational Biomarker Discovery Framework#261205bioRxiv / medRxiv
• Is there a cognitive measure of neurodegeneration for amyloid-Aβ-ratio probable Alzheimer's disease patients?#262904NCBI PubMed Central
• Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease.#263033NCBI PubMed Central
• Improved Multiscale Structural Mapping with Supervertex Vision Transformer for the Detection of Alzheimer's Disease Neurodegeneration.#265271NCBI PubMed Central
• Practice variations for fetal and neonatal congenital heart disease within the Children's Hospitals Neonatal Consortium.#280966NCBI PubMed Central
• Deep-learning saturation transfer magnetic resonance fingerprinting (ST-MRF) in patients with Parkinson's disease.#285018NCBI PubMed Central
• Neuropathological study of the effects of aducanumab anti-Aβ immunotherapy on patients with Alzheimer's disease.#288590NCBI PubMed Central
• Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial.#247570NCBI PubMed Central
• Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer's disease continuum.#607NCBI PubMed Central
• Enhanced meta ensemble stacking approach with XGBoost and optuna based detection of Parkinson's disease.#1371NCBI PubMed Central
• Brain network dynamics determine tau presence while regional vulnerability governs tau load in Alzheimer’s disease#4852Europe PMC
• Diagnostic performance of salivary markers of Alzheimer's disease: A systematic review#5490Europe PMC
• Gait asymmetry in Parkinson's disease - a systematic review and meta-analysis (AsymmGait-Parkinson study)#5518Europe PMC
• Targeting of Itch by clomipramine or gene therapy improves cognitive defects related to Alzheimer's disease#5586Europe PMC
• APOE-stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's Disease.#9004NCBI PubMed Central
• Discrepant Views of Apathy in Patients and Caregivers: the Role of Cognitive Deficits in Parkinson's Disease.#9030NCBI PubMed Central
• AI-Enabled Flexible Sensing Ecosystems for Parkinson’s Disease: Advancing Digital Biomarkers and Closed-Loop Interventions.#9450NCBI PubMed Central
• Aladynoulli: A Bayesian approach to disease progression modeling for genomic discovery and clinical prediction#10159bioRxiv / medRxiv
• Clustering reveals diagnostic overlap between Still’s disease and a hyperinflammatory subset of seronegative rheumatoid arthritis#15442HAL (France)
• Comparative Analysis of Task-Specific and Combined Upper-Limb EMG Features for Early Parkinson's Disease Classification#18833bioRxiv / medRxiv
• Evaluating the peripheral nervous system pathology of Alzheimer's disease utilizing a functional human NMJ microphysiological system.#28211NCBI PubMed Central
• Serum albumin and uric acid: biomarkers of neurocognitive and physical function in early Parkinson's disease.#30819NCBI PubMed Central
• Elevated plasma klotho levels attenuate Alzheimer's disease pathologies and cognitive decline in APOE ε4 carriers.#30862NCBI PubMed Central
• Deconstructing bilingualism and its sociocultural determinants in cognitive aging and Alzheimer's disease and related dementias.#125255NCBI PubMed Central
• Feasibility of identifying factors related to Alzheimer's disease and related dementia in real-world data.#138572NCBI PubMed Central
• Predicting long term clinical outcomes in Parkinson’s Disease using short term rating scales#142953Unpaywall
• SPECT and PET imaging of Alzheimer's disease revisited: from biomarkers to artificial intelligence-based prediction.#145997NCBI PubMed Central
• PROMISE-AD: Progression-aware Multi-horizon Survival Estimation for Alzheimer's Disease Progression and Dynamic Tracking#146928arXiv CS
• Identification of Alzheimer's disease subtypes and biomarkers from human multi-omics data using subspace merging algorithm.#148140NCBI PubMed Central
• Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer’s disease#151301Unpaywall
• Developing Facial and Speech Digital Tools for Clinical Assessments of Patients with Huntington's Disease: An Exploratory Study#151825Zenodo (CERN)
• Varying patterns of association between cortical large-scale networks and subthalamic nucleus activity in Parkinson's disease.#152130NCBI PubMed Central
• Asymptomatic Versus Symptomatic Alzheimer's Disease Neuropathology: A Systematic Review of Differences Reported in Post-Mortem Studies.#170487NCBI PubMed Central
• Virtual reality-based training in patients with alzheimer's disease: A systematic review and meta-analysis.#170749NCBI PubMed Central
• The Neuroprotective Role of Passive Music Therapy in Alzheimer's Disease: Effects on Cortisol Regulation and Stress Reduction#176379Zenodo (CERN)
• Exploring Preferences and Priorities in Advanced Parkinson’s Disease: A Discrete Choice Experiment#180563Springer Nature OA
• The pharmaceutical industry's multifaceted role in neglected tropical disease control: from market failure to global health innovation.#182582NCBI PubMed Central